Trends in Cardiovascular Risk Factors, Disease Management, and Predicted Cardiovascular Risk Among US Adults, 1999–2023
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Cardiovascular risk factors have changed in the United States, but trends in prevalence, management, and predicted risk through the post-pandemic period remain incompletely characterized.
Methods
We analyzed 11 National Health and Nutrition Examination Survey (NHANES) periods (1999–2000 through 2021–2023) among 60,199 nonpregnant adults aged ≥20 years. Survey-weighted regression assessed age-standardized trends, subgroup differences, and measurement-change sensitivity. We assessed awareness, treatment, and control of hypertension, dyslipidemia, and diabetes. PREVENT equations estimated 10- and 30-year risks among adults without self-reported cardiovascular disease (CVD).
Results
Obesity increased from 47.4% to 57.2% (odds ratio [OR] per decade, 1.23; 95% CI, 1.16–1.30), with class III obesity more than doubling (4.7% to 9.7%). Diabetes increased from 8.2% to 12.7% (OR, 1.26; 95% CI, 1.19–1.34), while current smoking declined from 24.4% to 14.9% (OR, 0.76; 95% CI, 0.71–0.81). Hypertension, dyslipidemia, chronic kidney disease, and prior CVD showed no significant linear trends, although mean systolic blood pressure (BP) (124.2 to 120.2 mm Hg) and total cholesterol (203.6 to 188.1 mg/dL) declined, alongside improvements in other lipids. Hypertension and dyslipidemia awareness and treatment increased, but BP control peaked at 32.5% in 2013–2014 before declining to 21.5%, while LDL cholesterol control rose from 17.0% to 34.2%. Diabetes awareness increased, but treatment trends were nonsignificant. Glycemic control peaked at 51.2% in 2003–2004 before declining to 41.9% (P for nonlinearity <0.001). Predicted 10-year total CVD risk declined from 5.66% to 5.28%; atherosclerotic CVD (ASCVD) risk declined by 0.16 percentage points per decade (95% CI, −0.22 to −0.09), while heart failure (HF) risk increased by 0.10 (95% CI, 0.03–0.17). Their 2021–2023 estimates were nearly identical (3.20% and 3.19%, respectively); 30-year risks showed similar divergence.
Conclusions
Improvements in smoking, blood pressure, and lipids coexisted with rising obesity and diabetes, declining blood pressure control after earlier gains, and divergent predicted ASCVD and HF risks.